Skip to main content
MEDICOX Co., Ltd. logo

MEDICOX Co., Ltd. — Investor Relations & Filings

Ticker · 054180 ISIN · KR7054180005 KO Manufacturing
Open in API
Filings indexed 803 across all filing types
Latest filing 2021-08-24 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 054180

About MEDICOX Co., Ltd.

https://www.medicox.co.kr

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a South Korean company, Medicox, detailing a decision for a third-party capital increase (유상증자결정). This type of filing is a regulatory requirement for public companies in Korea to disclose significant corporate actions such as capital structure changes, share issuance, or financing activities. Based on the provided definitions, this falls under 'Share Issue/Capital Change' (SHA) as it specifically details the issuance of new shares, the purpose of the capital raise, and the allocation to a third party.
2021-08-24 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'MEDICOX Co., Ltd.' (주식회사 메디콕스) for the period ending June 30, 2021. It contains detailed corporate information, financial data, management discussion, and governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This type of filing is a mandatory disclosure for major shareholders or executives when their shareholding status changes. In the context of the provided categories, this falls under 'Major Shareholding Notification' (MRQ), as it details the change in ownership percentage (from 7.74% to 5.42%) by a major shareholder (Ocean Renaissance Private Equity Fund) in the company Medicoz.
2021-07-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in shareholding percentage by a major shareholder (Ocean Renaissance Private Equity Fund) in the company 'Medicox'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2021-07-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease in shares held by a major shareholder) and is filed with the Financial Services Commission and the Korea Exchange. This falls under the category of Major Shareholding Notification.
2021-07-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a South Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) when an insider or major shareholder changes their stake in a company. This specific type of filing is categorized as a 'Director's Dealing' (DIRS) in our taxonomy, as it reports the personal share transactions of a major shareholder (Mecox Biomed) in the issuing company (Medicox).
2021-07-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.